Audit Committee

The Audit Committee comprises of the following members:

Mrs. Latika Pradhan Chairperson (Independent Director)
Dr. V. Raghunathan Member (Independent Director)
Mr. S. Subramaniam Member (Independent Director)

Terms of Reference

The Audit Committee meets at frequent intervals and the terms of reference of the audit committee as required under Section 177 of the Companies Act, 2013 and Regulation 18 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are as follows: 

  1. Overseeing the Company’s financial reporting process and disclosure of its financial information to ensure that its financial statements are correct, sufficient and credible;
  2. Recommending to the Board the appointment, re-appointment and replacement, remuneration and terms of appointment of the statutory auditor of the Company and the fixation of audit fee;
  3. Reviewing and monitoring the statutory auditor’s independence and performance, and effectiveness of audit process;
  4. Approving payments to statutory auditors for any other services rendered by the statutory auditors;
  5. Reviewing, with the management, the annual financial statements and auditor’s report thereon before submission to the Board for approval, with particular reference to:
    1. Matters required to be included in the Director’s Responsibility Statement to be included in the Board’s report in terms of clause (c) of sub-section 3 of Section 134 of the Companies Act, 2013, as amended;
    2. Changes, if any, in accounting policies and practices and reasons for the same;
    3. Major accounting entries involving estimates based on the exercise of judgment by management;
    4. Significant adjustments made in the financial statements arising out of audit findings;
    5. Compliance with listing and other legal requirements relating to financial statements;
    6. Disclosure of any related party transactions; and
    7. Qualifications in the draft audit report.
  1. Reviewing, with the management, the quarterly, half-yearly and annual financial statements before submission to the Board for approval;
  2. Reviewing, with the management, the statement of uses/ application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilized for purposes other than those stated in the offer document/ prospectus/ notice and the report submitted by the monitoring agency monitoring the utilization of proceeds of a public or rights issue, and making appropriate recommendations to the Board to take up steps in this matter. This also includes monitoring the use/application of the funds raised through the proposed Offer by the Company;
  3. Approval or any subsequent modifications of transactions of the Company with related parties;
  4. Scrutinizing of inter-corporate loans and investments;
  5. Valuing of undertakings or assets of the Company, wherever it is necessary;
  6. Evaluating of internal financial controls and risk management systems;
  7. Establishing a vigil mechanism for directors and employees to report their genuine concerns or grievances;
  8. Reviewing, with the management, the performance of statutory and internal auditors, and adequacy of the internal control systems;
  9. Reviewing the adequacy of internal audit function if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;
  10. Discussing with internal auditors on any significant findings and follow up there on;
  11. Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board;
  12. Discussing with statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern;
  13. Looking into the reasons for substantial defaults in the payment to the depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors;
  14. Reviewing the functioning of the whistle blower mechanism;
  15. Reviewing the management discussion and analysis of financial condition and results of operations;
  16. Approving the appointment of the chief financial officer or any other person heading the finance function or discharging that function after assessing the qualifications, experience and background, etc. of the candidate; and
  17. Carrying out any other function as is mentioned in the terms of reference of the Audit Committee;
  18. Statement of Deviations:
  1. Quarterly statement of deviation(s) including report of monitoring agency, if applicable, submitted to stock exchange (s) in terms of Regulation 32 (1)
  2. Annual statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice in terms of Regulation 32(7).

Nomination and Remuneration Committee

The Nomination and Remuneration Committee comprising of the following members:

Mr. Zarir Batliwala Chairman (Independent Director)
Mr. Narayan Ramchandran Member (Non-Executive Chairman and Lead Independent Director)
Mr. Mekin Maheshwari Member (Independent Director)
Mrs. Meenakshi Nevatia Member (Independent Director)

The terms of reference for the Nomination and Remuneration Committee are as follows:

  1. Formulating the criteria for determining qualifications, positive attributes and independence of a director and recommending to the Board a policy, relating to the remuneration of the directors, key managerial personnel and other employees;
  2. Formulating of criteria for evaluation of the independent directors and the Board;
  3. Devising a policy on Board diversity;
  4. Identifying persons who qualify to become directors or who may be appointed in senior management in accordance with the criteria laid down, recommending to the Board their appointment and removal, and carrying out evaluations of every director’s performance;
  5. Determining the company’s policy on specific remuneration packages for executive directors including pension rights and any compensation payment, and determining remuneration packages of such directors;
  6. Determine compensation levels payable to the senior management personnel and other staff (as deemed necessary), which shall be market-related, usually consisting of a fixed and variable component;
  7. Reviewing and approving compensation strategy from time to time in the context of the then current Indian market in accordance with applicable laws;
  8. Perform such functions as are required to be performed by the compensation committee under the Securities and Exchange Board of India (Share Based Employee Benefits) Regulations, 2014].
  9. Whether to extend or continue the terms of appointment of the independent director, on the basis of the report of performance evaluation of independent directors.

Stakeholders’ Relationship Committee

The Stakeholders’ Relationship Committee comprises of the following members:

Mrs. Latika Pradhan Chairperson (Independent Director)
Dr. V. Raghunathan Member (Independent Director)
Mr. Zarir Batliwala Member (Independent Director)

The terms of reference as amended by the regulators from time to time are frequently reviewed and appended to the committee charter. The existing terms of reference for the Committee is as follows:

  1. Redressal of shareholders’/investors’ grievances;
  2. Allotment of shares, approval of transfer or transmission of shares, debentures or any other securities;
  3. Issue of duplicate certificates and new certificates on split/consolidation/renewal;
  4. Non-receipt of declared dividends, balance sheets of the Company or any other documents or information to be sent by the Company to its shareholders; 
  5. Carrying out any other function as prescribed under in the Equity Listing Agreement; and
  6. The Committee shall consider and resolve the grievances of the security holders of the listed entity including complaints related to transfer of shares, non-receipt of annual report and non- receipt of declared dividends.

Corporate Social Responsibility Committee

The Corporate Social Responsibility Committee comprises of the following members:

Dr. V. Raghunathan Chairman (Independent Director)
Mrs. Latika Pradhan Member (Independent Director)
Mr. Mekin Maheshwari Member (Independent Director)

The terms of reference of the Corporate Social Responsibility Committee of our Company include the following:

  1. Formulate and recommend to the Board a Corporate Social Responsibility Policy (“CSR Policy”) 
  2. Recommend the amount of expenditure to be incurred on the activities referred to in clause (i);
  3. Monitor the Corporate Social Responsibility Policy of the company from time to time; and
  4. Monitor the amount approved by the Board is spent for the purpose and report the same to the Board.

Risk Management Committee

The Risk Management Committee comprises of the following members:

Mr. Narayan Ramchandran Chairman (Non-Executive Chairman and Lead Independent Director)
Mr. Manish Sabharwal Member (Executive Director)
Mr. Ashok Reddy Member (Executive Director)
Mr. Zarir Batliwala Member (Independent Director)
Mrs. Latika Pradhan Member (Independent Director)
Dr. V. Raghunathan Member (Independent Director)
Mr. Mekin Maheshwari Member (Independent Director)
Mrs. Meenakshi Nevatia Member (Independent Director)
Mr. S. Subramaniam Member (Independent Director)

The Board of the Company has formed a risk management committee to frame, implement and monitor the risk management plan for the Company. The committee is responsible for reviewing the risk management plan and ensuring its effectiveness. Major risks identified by the businesses and functions are systematically addressed through mitigating actions on a continuous basis

In adherence to the present regulatory mandates, the Risk Management Committee of the Board of Directors of the Company shall, through the Core Committee, formed for the purpose:

  •  Ensure an organization relevant and perpetual Risk Management framework for identifying, assessing, responding to, monitoring or controlling and reporting risks.
  •  Apply an organized, thorough approach to effectively anticipate and mitigate the
    probable or realistic risks that could endanger achievement of key objectives.
  • Ensure systemic risk evaluation, categorization, and prioritization thereof to assign
    relative importance to identified risks to determine where appropriate management attention is required.
  • Evaluate significant risk exposures of the Company and assess management's actions to
    mitigate the exposures in a timely manner (including one-off initiatives, and ongoing
    activities such as business continuity planning and disaster recovery planning & testing).
  • Practice the highest level of control measures by installing mechanisms and tools, with
    involvement of all process-owners across the organization, to ensure that all applicable
    legal, regulatory, and business requirements are up-to-date and met.
  • Develop alternative/ recommended courses of action for critical risks and control the
    probability of occurrence of the risk, keeping ready contingency plans for selected risks
    where the consequences of the risks are determined to be high.
  • Review the activities, status, and results of the risk management process on a periodic
    and event-driven basis with appropriate levels of management and resolve issues i.e.
    gauging potential risk exposure and addressing the same with appropriate corrective action.
  • Obtain, wherever required or desirable, the advice, opinion and assistance from outside
    legal, accounting, or other advisors, as necessary, to aid informed decision making.
  • Co-ordinate its activities with the Audit Committee in instances where there is any
    overlap with audit activities (e.g. internal or external audit issue relating to risk management policy or practice).